Survodutide is new weight loss drug acts as a dual glucagon/GLP-1 receptor agonist activates the GLP-1 and glucagon receptors crucial for controlling the metabolism .This weekly once injectable medication, jointly developed by Zealand and Boehringer Ingelheim, targets obesity and nonalcoholic steatohepatitis (NASH), a type of liver disease.

In a Phase 2 trial involving 387 adults with overweight or obesity but no diabetes, 83% of them showed positive results for NASH-related liver inflammation. While Survodutide is still in developmental stage , It has received fast-track designation from the U.S. Food and Drug Administration for treatment of MASH and fibrosis

Starts at £0
Please find below product pricing:
Brand Medicine Strength Size Price
- 1 0.00

It looks like you missed filling in questions from the last consultation.Click Here to submit your response.

Notify me once available

Out of Stock
  • No prescription required
  • Online assessment
  • No hidden fees
You’re almost there!

It is the prescribers duty to ensure that the medicine is being used safely and appropriately. please answer a few questions about yourself to help us process your request.

- Manesha

Customer Service Team

Confidentiality & Authenticity Assured

  • Fully Regulated UK Pharmacy
  • Authentic UK sourced medicines only.
  • Trading for more than 10 years.
  • Information Governance lead ensures all data is confidential

Need Help With Your Questionnaire?

Our customer service team is on hand Monday-Friday to help you with your queries.

Please call us on 08009788956 or
email us at:


UK licenced

100% Discretion
& Confidentiality

Cancel any

About Survodutide :

Unlike other dual GLP-1/glucagon dual agonists, it is an glucagon analog rather than an analog of oxyntomodulin. It means that survodutide is based on the properties of glucagon, a hormone involved in regulating blood sugar levels, rather than oxyntomodulin, another hormone with similar effects on metabolism. This distinction may impact the specific mechanisms of action and result in potential therapeutic effects of Survodutide compared to other dual agonists.

Side effects of Survodutide :

The safety analysis of the trial showed that there arwe no unexpected safety concerns or issues with tolerability, including with the 6.0 mg dose.

Is Survodutide available in stock in the UK?

Survodutide has not yet been approved or released for purchase in the UK. It is still in developmental phase and as soon as it becomes available, you can buy online in Pharmacy planet for the lowest price in the UK for weight loss treatment.

Are there any alternative treatments for weight loss?

Yes,  there are other drugs such as Mounjaro , Ozempic and Wegovy are available for treating weight loss or obesity. Your healthcare provider can help you figuring out the right medicine for you. Alternatively, you can opt for an online medical consultation with us, where our clinicians will guide you towards the most appropriate solution.

Be the first to know

Sign up to be the first to know when Survodutide becomes available by clicking the 'Notify me once available' button above and enter your email. We'll keep you up to date with the latest developments concerning Survodutide and let you know as soon as it becomes available in the UK.